CDC26 facilitates ferroptosis through SLC7A11 degradation and cell cycle arrest

Area of Science:

• Biochemistry
• Cell Biology
• Oncology

Background:

• The ubiquitin proteasome system (UPS) is crucial for protein degradation and cellular homeostasis.
• E3 ubiquitin ligases, key UPS components, regulate cell fate by targeting specific proteins for degradation.
• Ferroptosis, a regulated cell death form, is influenced by the UPS, particularly E3 ligases.

Purpose of the Study:

• To investigate the role of E3 ubiquitin ligases in ferroptosis within pancreatic ductal adenocarcinoma (PDAC).
• To identify novel regulators of ferroptosis in PDAC and elucidate their mechanisms of action.

Main Methods:

• Screening of 286 E3 ligases involved in the UPS.
• Functional analysis of identified E3 ligases in PDAC cells.
• Investigation of the molecular mechanisms underlying E3 ligase-mediated ferroptosis.

Main Results:

• Cell division cycle 26 (CDC26) was identified as an E3 ligase that induces ferroptosis in PDAC cells.
• CDC26 expression is downregulated during ferroptosis in PDAC.
• CDC26 overexpression enhances ferroptosis by increasing reactive oxygen species (ROS) and lipid peroxidation, suppressing proliferation and invasion.
• CDC26 promotes the degradation of SLC7A11, a ferroptosis inhibitor, and inhibits the cell cycle.

Conclusions:

• CDC26 acts as a ferroptosis inducer in PDAC, linking the UPS and ferroptosis pathways.
• CDC26's mechanism involves targeting SLC7A11 for degradation and cell cycle inhibition.
• CDC26 represents a potential therapeutic target for pancreatic cancer treatment.